|
Volumn 148, Issue 1, 2015, Pages 262-263
|
Reply
a,b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ICOSAPENTAENOIC ACID;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
CLINICAL TRIAL (TOPIC);
DISEASE COURSE;
HISTOPATHOLOGY;
HUMAN;
LETTER;
LIVER BIOPSY;
METABOLIC SYNDROME X;
MORBIDITY;
MORTALITY;
NONALCOHOLIC FATTY LIVER;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
RISK FACTOR;
SCORING SYSTEM;
ANALOGS AND DERIVATIVES;
DRUG EFFECTS;
FATTY LIVER;
FEMALE;
LIVER;
MALE;
EICOSAPENTAENOIC ACID;
FATTY LIVER;
FEMALE;
HUMANS;
LIVER;
MALE;
|
EID: 84922950605
PISSN: 00165085
EISSN: 15280012
Source Type: Journal
DOI: 10.1053/j.gastro.2014.11.030 Document Type: Letter |
Times cited : (2)
|
References (2)
|